New Product Development
Pneumococcal vaccines market size, which offer a powerful defence against illnesses caused by the Streptococcus pneumoniae bacteria, are an essential part of world health. These bacteria are harmful because they can lead to a number of illnesses, including sepsis, meningitis, and pneumonia. They pose a particular risk to small children, the elderly, and those with …
Continue reading “Pneumococcal Vaccines Market Sets Course to Surpass US$ 13.3 Billion by 2033”
In its upcoming report titled “Pneumococcal Vaccines Market Throughout the forecast period, a CAGR of 4.1% is expected to be achieved on average by the global market for pneumococcal vaccinations. The market is currently estimated to be worth US$ 8.9 billion in 2023. By 2033, it’s expected that the market for pneumococcal vaccinations would be worth …
During the forecast period, the global Pneumococcal Vaccines Market is expected to grow at a 4.1% CAGR. In 2023, the market is currently valued at US$ 8.9 billion. The pneumococcal vaccines market is expected to exceed a market valuation of US$ 13.3 billion by 2033. Future Market Insights analysts recorded a historical market valuation of …
In its upcoming report titled “Pneumococcal Vaccines Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018 – 2028,” Future Market Insights (FMI) provides key insights on the Global Pneumococcal Vaccines Market. In terms of revenue, the global pneumococcal vaccines market is expected to grow at a 9.1% CAGR during the forecast period. A sample of …
